1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Galera Therapeutics, Inc.

Galera Therapeutics, Inc.

GRTX
Galera Therapeutics, Inc.US flagOther OTC
0.10
USD
+0.00
- -
7.59MMarket Cap

Income Statement (USD)

APIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
24
24
51
71
73
51
47
14
6
+ Selling, General & Admin
4
6
8
16
21
20
23
11
6
+ Research & Development
21
19
42
55
52
31
24
3
- -
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-24
-24
-51
-71
-73
-51
-47
-14
-6
- Non-Operating (Income) Loss
- -
- -
1
4
7
11
12
5
-155
+ Interest Expense, Net
- -
- -
1
4
7
11
10
-1
- -
+ Interest Expense
- -
- -
3
5
7
12
11
- -
- -
- Interest Income
- -
1
2
1
- -
1
2
1
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
2
6
-155
Pretax Income
-24
-24
-52
-74
-81
-62
-59
-19
149
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-24
-24
-52
-74
-81
-62
-59
-19
149
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-24
-24
-52
-74
-81
-62
-59
-19
149
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-24
-24
-52
-74
-81
-62
-59
-19
149
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-24
-24
-52
-74
-81
-62
-59
-19
149
EBIT
-24
-24
-51
-71
-73
-51
-47
-14
-6
EBITDA
-24
-24
-50
-70
-73
-51
-47
-14
-6
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
EBITA
-24
-24
-51
-71
-73
-51
-47
-14
-6
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
1
- -
- -
- -
- -
Basic Weighted Avg Shares
15
19
25
25
26
27
45
55
- -
Basic EPS, GAAP
-1.55
-1.22
-2.09
-2.98
-3.12
-2.3
-1.33
-0.35
- -
Basic EPS from Cont Ops
-1.55
-1.22
-2.09
-2.98
-3.12
-2.3
-1.33
-0.35
- -
Diluted Weighted Avg Shares
15
19
25
25
26
27
45
55
- -
Diluted EPS, GAAP
-1.55
-1.22
-2.09
-2.98
-3.12
-2.3
-1.33
-0.35
- -
Diluted EPS from Cont Ops
-1.55
-1.22
-2.09
-2.98
-3.12
-2.3
-1.33
-0.35
- -

Balance Sheet (USD)

APIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
15
84
118
78
77
39
22
10
7
+ Cash, Cash Equivalents & STI
14
82
112
73
71
32
18
8
6
+ Cash & Cash Equivalents
6
15
18
16
20
4
18
8
6
+ ST Investments
8
67
94
57
51
27
- -
- -
- -
+ Accounts & Notes Receiv
1
1
- -
- -
- -
- -
- -
1
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
1
1
- -
- -
- -
- -
- -
1
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
5
5
6
7
3
1
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
4
4
6
6
6
6
5
- -
- -
+ Property, Plant & Equip, Net
- -
1
2
2
1
- -
1
- -
- -
+ Property, Plant & Equip
1
1
2
2
2
2
2
- -
- -
- Accumulated Depreciation
- -
- -
- -
1
2
2
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
3
4
4
5
5
5
3
- -
- -
+ Total Intangible Assets
3
3
3
3
3
3
3
- -
- -
+ Goodwill
1
1
1
1
1
1
1
- -
- -
+ Other Intangible Assets
2
2
2
2
2
2
2
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
1
1
2
2
- -
- -
- -
Total Assets
19
88
123
84
83
44
26
10
7
+ Payables & Accruals
4
6
8
11
11
11
5
2
1
+ Accounts Payable
2
4
4
5
5
4
1
1
- -
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
2
4
6
6
7
3
- -
- -
+ ST Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
1
1
1
3
2
3
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
1
1
3
2
3
- -
- -
- -
Total Current Liabilities
4
6
10
14
13
13
5
2
1
+ LT Debt
- -
- -
1
- -
- -
- -
1
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
1
- -
- -
- -
1
- -
- -
+ Other LT Liabilities
91
186
44
64
128
140
151
152
- -
+ Accrued Liabilities
1
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
90
186
43
63
128
140
151
152
- -
Total Noncurrent Liabilities
91
186
44
64
128
140
152
152
- -
Total Liabilities
95
193
54
78
141
153
157
154
1
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
4
3
+ Share Capital & APIC
- -
- -
231
242
258
269
306
308
311
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
231
242
258
269
306
308
311
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-76
-105
-161
-236
-316
-378
-437
-456
-307
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-76
-105
70
6
-58
-109
-131
-144
7
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-76
-105
70
6
-58
-109
-131
-144
7
Total Liabilities & Equity
19
88
123
84
83
44
26
10
7
Shares Outstanding
24
24
25
25
26
29
54
75
75
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
1
1
- -
- -
1
- -
- -
Net Debt
-6
-15
-18
-16
-20
-4
-18
-8
-6
Net Debt to Equity
8.11
14.13
-26.37
-259.43
34.24
3.91
13.92
5.77
-97.31
Tangible Common Equity Ratio
-503.68
-127.13
55.28
3.68
-76.26
-274.64
-583.97
-1,465.61
55.23
Current Ratio
3.53
13.01
12.13
5.58
5.98
2.88
4.36
6
11
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-24
-24
-52
-74
-81
-62
-59
-19
149
+ Depreciation & Amortization
- -
- -
- -
- -
1
- -
- -
- -
- -
+ Non-Cash Items
1
1
6
10
14
19
17
9
-154
+ Stock-Based Compensation
1
1
2
6
7
7
6
3
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
3
- -
+ Other Non-Cash Adj
- -
- -
3
5
7
12
11
3
-155
+ Chg in Non-Cash Work Cap
-1
1
-1
4
-3
- -
-3
-2
-1
+ (Inc) Dec in Accts Receiv
- -
- -
1
- -
- -
-3
3
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
-4
- -
-1
3
1
2
- -
+ Inc (Dec) in Accts Payable
- -
2
3
4
-1
1
-9
-4
-1
+ Inc (Dec) in Other
- -
- -
- -
- -
-1
- -
2
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-23
-22
-47
-60
-68
-43
-45
-12
-6
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
4
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
4
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-1
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
-1
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
58
- -
8
4
29
2
1
+ Increase in Capital Stock
- -
- -
58
- -
8
4
29
2
1
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
24
-59
-27
37
6
24
27
- -
- -
+ Dec in LT Investment
34
13
96
105
78
84
50
- -
- -
+ Inc in LT Investment
-10
-71
-123
-68
-72
-60
-23
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
24
-59
-28
37
5
24
27
- -
4
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
90
20
21
59
- -
2
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
90
78
21
67
4
31
2
1
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
9
4
-2
4
-16
14
-10
-2
EBITDA
-24
-24
-50
-70
-73
-51
-47
-14
-6
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-24
-23
-47
-60
-68
-43
-45
-12
-6
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
-6
Free Cash Flow to Equity
- -
-23
-47
-60
-68
-43
-45
-8
-4
Free Cash Flow per Basic Share
-1.56
-1.16
-1.91
-2.41
-2.65
-1.6
-1.01
-0.22
- -
Price/Free Cash Flow
- -
- -
-7.09
-4.31
-1.75
-0.93
-0.14
-0.21
- -
Cash Flow to Net Income
0.99
0.94
0.9
0.8
0.84
0.7
0.76
0.64
-0.04
Capital Expenditures
- -
- -
-1
- -
- -
- -
- -
- -
- -